Lymphoma, B-cell, Diffuse
1 clinical trials · Condition
◉ Watch Lymphoma, B-cell, Diffuse
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma (NCT03900377) | SymBio Pharmaceuticals | 2019-04-01 |
Track Lymphoma, B-cell, Diffuse automatically
Every clearance here is in the API, with alerts when new ones post.